This message was posted by a user wishing to remain anonymous
Hello All,
Does anyone know if a DMF can be used to submit proprietary
nonclinical data to NMPA to support another sponsor's drug application in China? I know NMPA accepts DMFs for APIs, packaging materials, excipients and medical devices but have found no information on the acceptability of submitting other types of proprietary information in a DMF to the Chinese regulatory authority. Is there a Chinese equivalent to the U.S. Type V DMF?
Or, if a DMF is not viable for this purpose, is there another way to submit proprietary nonclinical data to NMPA?
Any feedback would be greatly appreciated!
Thank you